MoneyWorks4Me

Fermenta Biotech submits investor presentation

18 Nov 2019 Evaluate

Further to intimation dated November 13, 2019 regarding approval of Unaudited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter and half year ended September 30, 2019, Fermenta Biotech has informed about submission of a copy of Investor Presentation for November 2019. The said Investor Presentation is also available on Company’s website www.dil.net. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..